Title
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Autoimmune Disorders and Rheumatoid Arthritis: The Connection

Written By

Why This Was Updated?

Our specialists regularly review advancements in health and wellness, ensuring our articles are updated with the newest information as it becomes accessible.
Medically Reviewed by
Dr.
Ayesha Bryant
MSPH, MD

‍Autoimmune disorders represent a complex challenge in medicine, where the body's defense mechanisms turn inward, attacking its tissues. Among these conditions, Rheumatoid Arthritis (RA) is particularly significantβ€”not only for its debilitating effects on the joints but also for its connections to a broader network of autoimmune diseases.

This article explores the intricate relationship between RA and other autoimmune disorders, shedding light on the underlying mechanisms that link these conditions. By exploring these connections, we aim to understand better how RA fits within the wider context of autoimmune diseases and why this knowledge is vital for more effective treatment and management.

[signup]

Understanding Autoimmune Disorders

Autoimmune disorders occur when the body's immune system mistakenly attacks healthy cells, tissues, and organs, leading to various health issues.Β 

In a healthy immune system, blood cells and antibodies work together to protect the body from harmful invaders. The immune system identifies foreign substances through antigens and mounts an appropriate response to eliminate them.Β 

Autoimmune disorders disrupt this process, causing the immune system to attack the body's own cells. This misidentification can be triggered by genetic factors, environmental exposures, or infections, though the exact cause is often unknown.

Autoimmune disorders share several common characteristics:

There are over 80 recognized autoimmune disorders, with some of the most common including:

Rheumatoid Arthritis as an Autoimmune Disorder

Rheumatoid arthritis (RA) is an autoimmune disease because it involves the immune system mistakenly attacking the body's own tissues, specifically the synovium, which is the lining of the joints. This attack leads to inflammation, thickening of the synovial membrane, and eventually joint damage.Β 

The immune system's response to RA is characterized by the production of autoantibodies, such as rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA). These antibodies target the body's own proteins, contributing to the disease's progression.

Rheumatoid Arthritis presents itself through a variety of symptoms, many of which are common to other forms of arthritis but with unique characteristics that highlight its autoimmune nature:

  • Joint Pain: One of the most common symptoms of RA, joint pain is often symmetrical, meaning it affects the same joints on both sides of the body. The pain is usually worse in the morning or after periods of inactivity.
  • Stiffness: Morning stiffness lasting more than 30 minutes is a classic sign of RA. Unlike the stiffness in osteoarthritis, which usually improves after a few minutes of movement, RA-related stiffness can linger for hours.
  • Swelling: Joints affected by RA often appear swollen due to inflammation. This swelling can be accompanied by warmth and redness, signaling active inflammation.
  • Systemic Symptoms: Unlike some other forms of arthritis, RA can cause symptoms that affect the entire body. Fatigue, low-grade fever, and a general feeling of malaise are common. Additionally, RA can affect other organs, leading to complications such as rheumatoid nodules, lung disease, and cardiovascular issues.

RA differs from other forms of arthritis, such as osteoarthritis, in its underlying mechanism and systemic nature. While osteoarthritis is primarily a degenerative joint disease caused by wear and tear, RA is an autoimmune condition with an immune-mediated inflammatory process.Β 

This immune component is what distinguishes RA from non-autoimmune types of arthritis. The presence of autoantibodies and systemic symptoms in RA highlight its autoimmune nature, whereas other forms of arthritis may not involve the immune system to the same extent.

The Connection Between RA and Other Autoimmune Disorders

People with rheumatoid arthritis (RA) often experience the coexistence of other autoimmune disorders. This phenomenon, known as polyautoimmunity, indicates that patients with RA are more likely to develop additional autoimmune diseases compared to those with non-autoimmune conditions like osteoarthritis (OA).Β 

For example, studies have shown that patients with RA have higher prevalence rates of systemic lupus erythematosus (SLE) and psoriatic arthritis compared to those with OA. Common autoimmune conditions that may coexist with RA include SjΓΆgren's syndrome, lupus, and psoriasis.

The development of RA and other autoimmune disorders is influenced by both genetic and environmental factors:

Genetic Predisposition: Certain genetic markers, particularly those related to the human leukocyte antigen (HLA) system, are associated with an increased risk of autoimmune diseases. For RA, the HLA-DRB1 gene is a significant genetic factor. These genes play a crucial role in immune system regulation, affecting how the body distinguishes between self and non-self molecules.

Environmental Triggers: Environmental factors such as infections, smoking, and exposure to certain chemicals can trigger autoimmune responses. Smoking, in particular, is a well-established risk factor for RA, significantly increasing the risk, especially in individuals who are rheumatoid factor positive. Other potential environmental influences include hormonal changes and dietary factors.

Chronic inflammation is a central feature of RA and can contribute to or exacerbate other autoimmune conditions. The systemic nature of inflammation in RA means that it can affect multiple organs and tissues, leading to a range of comorbidities.Β 

This persistent inflammatory state can increase the risk of developing additional autoimmune diseases as the immune system remains in a heightened state of activation. The overlap in cytokine pathways and immune mechanisms among autoimmune diseases suggests that systemic inflammation in RA may create a conducive environment for developing other autoimmune disorders.

Immune System Dysfunction in RA and Other Autoimmune Disorders

In autoimmune disorders like rheumatoid arthritis (RA), the immune system becomes dysregulated and mistakenly attacks the body's tissues. This dysregulation is often influenced by genetic factors, such as specific HLA genes, and environmental triggers like infections and smoking, which can activate the immune system inappropriately.

Cytokines are crucial in promoting inflammation in RA and other autoimmune conditions. In RA, cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) are key mediators of the inflammatory process.Β 

These cytokines are produced by immune cells like macrophages and T-cells and contribute to RA's chronic inflammation and joint damage. They stimulate the proliferation of synovial cells and the production of other inflammatory mediators, perpetuating the cycle of inflammation and tissue destruction.

The immune system can mistakenly attack different tissues due to cross-reactivity and molecular mimicry, leading to multiple autoimmune disorders. Cross-reactivity occurs when immune cells recognize similar antigens on different tissues, while molecular mimicry involves the immune system targeting self-antigens that resemble foreign antigens.Β 

These mechanisms can cause the immune system to attack various tissues, resulting in the coexistence of multiple autoimmune diseases. This is why individuals with one autoimmune disorder, like RA, may be more susceptible to developing others, such as SjΓΆgren's syndrome or lupus.

Diagnosing Multiple Autoimmune Disorders

Diagnosing multiple autoimmune disorders can be particularly challenging due to the overlapping symptoms among different conditions. For instance, rheumatoid arthritis (RA) shares symptoms such as joint pain, swelling, and fatigue with other autoimmune diseases like lupus and SjΓΆgren's syndrome.Β 

This symptom overlap can complicate the diagnostic process, as it may be difficult to determine which autoimmune disorder is responsible for the symptoms or if multiple disorders are present simultaneously.

To diagnose RA and other autoimmune disorders, healthcare providers use a combination of tests and evaluations:

Blood Tests: These include tests for autoantibodies like rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) specific to RA, as well as antinuclear antibody (ANA) tests, complete blood count (CBC), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) levels to assess inflammation and immune activity. Here are some examples of these tests offered through Rupa Health:

Imaging: X-rays, ultrasounds, and MRIs can reveal joint damage or inflammation, aiding in diagnosing RA and distinguishing it from other conditions.

Biopsies: In some cases, tissue biopsies may be necessary to confirm the presence of certain autoimmune disorders, especially when skin or organ involvement is suspected.

A comprehensive evaluation, including a thorough medical history and physical examination, is crucial in identifying coexisting autoimmune conditions. Understanding a patient's complete medical history, including any family history of autoimmune diseases, can provide valuable insights into potential genetic predispositions and environmental triggers.Β 

This holistic approach helps healthcare providers differentiate between overlapping symptoms and identify the presence of multiple autoimmune disorders, ensuring accurate diagnosis and effective management.

Treatment Strategies for RA and Coexisting Autoimmune Disorders

When treating individuals with rheumatoid arthritis (RA) who also have coexisting autoimmune disorders, a tailored approach is essential. Treatment plans may differ significantly from those for patients with RA alone.Β 

For instance, while the primary goal in RA treatment is to reduce inflammation and prevent joint damage, other autoimmune conditions may necessitate additional therapies to address systemic symptoms and organ involvement.Β 

Personalized treatment strategies often involve a combination of pharmacologic and nonpharmacologic therapies, and they require careful monitoring to manage the complexities of multiple autoimmune diseases.

Medications Used Across Autoimmune Conditions

Several classes of medications are commonly used to treat RA and other autoimmune disorders:

Disease-Modifying Antirheumatic Drugs (DMARDs): These include methotrexate, sulfasalazine, leflunomide, and hydroxychloroquine, often the first line of treatment for RA. They work by slowing disease progression and reducing inflammation.

Biologics: Targeted therapies such as TNF inhibitors (e.g., etanercept, infliximab, adalimumab) and non-TNF biologics (e.g., rituximab, tocilizumab) inhibit specific pathways in the immune response, providing more precise control of inflammation.

Corticosteroids and NSAIDs: These are used to manage acute inflammation and pain but are typically not suitable for long-term use due to potential side effects.

Lifestyle and Holistic Approaches

In addition to pharmacologic treatments, lifestyle, and holistic approaches play a crucial role in managing RA and coexisting autoimmune disorders:

Diet: A balanced, nutritious diet can help reduce inflammation and maintain a healthy weight, which is crucial for joint health. Some patients may benefit from specific diets, such as the Mediterranean diet, which is rich in anti-inflammatory foods.

‍Exercise: Regular physical activity is important for maintaining joint function and overall health. Exercise programs should be tailored to individual capabilities and may include low-impact activities like swimming or cycling.

Stress Management: Stress can exacerbate autoimmune symptoms, so incorporating stress-reduction techniques such as mindfulness, yoga, or meditation can be beneficial.

Rest and Recovery: Balancing activity with adequate rest is essential, especially during flares of autoimmune activity. Techniques like hot and cold treatments can also help manage symptoms.

Living with RA and Other Autoimmune Disorders

Living with rheumatoid arthritis (RA) and other autoimmune disorders presents unique physical and emotional challenges. Strategies for coping include:

Education and Self-Management: Understanding the nature of each condition and its symptoms can empower individuals to manage their health effectively. This includes recognizing triggers that may exacerbate symptoms and learning how to mitigate them.

‍Symptom Management: Employing techniques such as pacing activities to manage fatigue, using assistive devices to reduce joint strain, and adhering to medication regimens to control inflammation and pain.

‍Emotional Support: Addressing the psychological impact of chronic illness through counseling or therapy can help manage stress, anxiety, and depression, which are common among those with multiple autoimmune conditions.

Support Systems and Resources

Support systems play a crucial role in managing life with multiple autoimmune disorders. Connecting with others who have similar experiences can provide emotional support and practical advice. These groups offer a sense of community and understanding that can be invaluable.

Professional counseling can also help individuals navigate the emotional complexities of living with chronic illnesses, providing strategies to cope with stress and improve mental health. Websites and forums dedicated to autoimmune diseases can offer information, support, and a platform for sharing experiences.

Monitoring and Long-Term Care

Regular monitoring and long-term care are essential for managing RA and other autoimmune diseases. Frequent medical appointments allow for monitoring disease progression and the effectiveness of treatment plans. Adjustments can be made as needed to address any changes in symptoms or the emergence of new conditions.

A thorough medical history and regular evaluations help identify coexisting autoimmune conditions early, allowing for timely intervention. Collaboration among healthcare providers, including rheumatologists, immunologists, and primary care physicians, ensures a comprehensive approach to treatment and management.

[signup]

Key Takeaways

  • Autoimmune disorders occur when the immune system mistakenly attacks healthy tissues, leading to inflammation and damage.
  • Rheumatoid arthritis (RA) specifically targets the synovium, causing joint pain and swelling.
  • Symptoms of autoimmune diseases often overlap, complicating diagnosis and management.
  • Individuals with RA are at a higher risk of developing other autoimmune conditions, such as lupus and SjΓΆgren's syndrome.
  • Diagnosis involves comprehensive evaluations, including blood tests for autoantibodies and imaging studies.
  • Treatment plans must be tailored for individuals with RA and coexisting autoimmune disorders, often involving DMARDs, biologics, and lifestyle modifications.
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.
Learn More
No items found.

Lab Tests in This Article

AlpΓ­zar-RodrΓ­guez, D., Pluchino, N., Canny, G., Gabay, C., & Finckh, A. (2016). The role of female hormonal factors in the development of rheumatoid arthritis. Rheumatology, 56(8), kew318. https://doi.org/10.1093/rheumatology/kew318

ANA 11 Components (no ANA Screen) by Access Med Labs. (2020). Rupa Health. https://www.rupahealth.com/lab-tests/access-medical-labs-ana-11-components-no-ana-screen

ANA by Empire City Laboratories Inc. (2020). Rupa Health. https://www.rupahealth.com/lab-tests/empire-city-labs-ana

Benjamin, O., Goyal, A., & Lappin, S. L. (2022, July 4). Disease Modifying Anti-Rheumatic Drugs (DMARD). PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK507863/

CBC w/ Diff by Access Medical Laboratories. (n.d.). Rupa Health. https://www.rupahealth.com/lab-tests/access-medical-labs-cbc-w-diff

CBC w/ Diff by Boston Heart Diagnostics. (2020). Rupa Health. https://www.rupahealth.com/lab-tests/bostonheart-cbc-w-diff

Cloyd, K. (2023, October 3). Functional Medicine Protocol for Autoimmune Diseases: Balancing the Immune System. Rupa Health. https://www.rupahealth.com/post/functional-medicine-protocol-for-autoimmune-diseases-balancing-the-immune-system

Cox, A. D. (2022a, August 10). Chronic Fatigue, Chest Pain, Stiffness, And Headaches Are All Signs Of This Autoimmune Disease. Rupa Health. https://www.rupahealth.com/post/natural-treatment-for-lupus

Cox, A. D. (2022b, September 8). 4 Herbs And Supplements That May Help Control Type 1 Diabetes. Rupa Health. https://www.rupahealth.com/post/a-root-cause-approach-to-managing-type-1-diabetes

Cyclic Citrullinated Peptide IgG Ab. by Access Med Labs. (2020). Rupa Health. https://www.rupahealth.com/lab-tests/access-medical-labs-cyclic-citrullinated-peptide-igg-ab

DeCesaris, L. (2023, June 7). 4 Genetic Tests That Can Help Individualize Treatment Options for Patients With Autoimmune Disease. Rupa Health. https://www.rupahealth.com/post/the-role-of-genetics-in-autoimmune-diseases

Dedmon, L. E. (2020). The genetics of rheumatoid arthritis. Rheumatology, 59(10). https://doi.org/10.1093/rheumatology/keaa232

DePorto, T. (2023, February 1). The Gut’s Role in The Development and Treatment of Psoriasis: A Integrative Medicine Approach. Rupa Health. https://www.rupahealth.com/post/the-guts-role-in-the-development-and-treatment-of-psoriasis-a-integrative-medicine-approach

Ding, Q., Hu, W., Wang, R., Yang, Q., Zhu, M., Li, M., Cai, J., Rose, P., Mao, J., & Zhu, Y. Z. (2023). Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduction and Targeted Therapy, 8(1), 1–24. https://doi.org/10.1038/s41392-023-01331-9

ESR by Empire City Laboratories Inc. (2020). Rupa Health. https://www.rupahealth.com/lab-tests/empire-city-labs-esr

Findeisen, K. E., Sewell, J., & Ostor, A. J. K. (2021). Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician. Biologics: Targets & Therapy, 15, 343–352. https://doi.org/10.2147/BTT.S252575

Firestein, G. S., & McInnes, I. B. (2017). Immunopathogenesis of Rheumatoid Arthritis. Immunity, 46(2), 183–196. https://doi.org/10.1016/j.immuni.2017.02.006

Flurey, C. A., Hewlett, S., Rodham, K., White, A., Noddings, R., & Kirwan, J. R. (2018). Coping Strategies, Psychological Impact, and Support Preferences of Men With Rheumatoid Arthritis: A Multicenter Survey. Arthritis Care & Research, 70(6), 851–860. https://doi.org/10.1002/acr.23422

Francesco Salvatore Iaquinta, Rivellese, F., & Costantino Pitzalis. (2023). Synovial biopsies for molecular definition of rheumatoid arthritis and treatment response phenotyping: where can we improve? Expert Review of Molecular Diagnostics, 23(12), 1071–1076. https://doi.org/10.1080/14737159.2023.2284774

Garrick, N. (2022, November). Rheumatoid arthritis. National Institute of Arthritis and Musculoskeletal and Skin Diseases. https://www.niams.nih.gov/health-topics/rheumatoid-arthritis/diagnosis-treatment-and-steps-to-take

Harnden, K., Di Matteo, A., & Mankia, K. (2022). When and how should we use imaging in individuals at risk of rheumatoid arthritis? Frontiers in Medicine, 9, 1058510. https://doi.org/10.3389/fmed.2022.1058510

High Sensitivity C-Reactive Protein (hs-CRP) by Boston Heart Diagnostics. (2020). Rupa Health. https://www.rupahealth.com/lab-tests/bostonheart-high-sensitivity-c-reactive-protein-hs-crp-cfb0e

High-Sensitivity C-Reactive Protein by Empire City Laboratories Inc. (2020). Rupa Health. https://www.rupahealth.com/lab-tests/empire-city-labs-high-sensitivity-c-reactive-protein

Ishikawa, Y., & Terao, C. (2020). The Impact of Cigarette Smoking on Risk of Rheumatoid Arthritis: A Narrative Review. Cells, 9(2), 475. https://doi.org/10.3390/cells9020475

Khakham, C. (2023a, May 3). How To Manage and Treat Autoimmune Disorders With Functional Testing and Nutrition. Rupa Health. https://www.rupahealth.com/post/how-to-manage-and-treat-autoimmune-disorders-with-functional-nutrition

Khakham, C. (2023b, May 22). A Comprehensive Review of Complementary and Integrative Medicine Approaches to the Management of Psoriatic Arthritis. Rupa Health. https://www.rupahealth.com/post/a-comprehensive-review-of-complementary-and-integrative-medicine-approaches-to-the-management-of-psoriatic-arthritis

Khakham, C. (2023c, June 8). Exploring the Complexities of Autoimmune Diseases: Unraveling Mechanisms, Risk Factors, and Integrative Approaches to Testing, Diagnosis, and Treatment. Rupa Health. https://www.rupahealth.com/post/understanding-autoimmune-diseases-mechanisms-and-risk-factors

Kim, J.-W., & Suh, C.-H. (2020). Systemic Manifestations and Complications in Patients with Rheumatoid Arthritis. Journal of Clinical Medicine, 9(6). https://doi.org/10.3390/jcm9062008

Kresge, K. (2022, October 31). IBS vs IBD: Know the symptoms. Rupa Health. https://www.rupahealth.com/post/ibs-vs-ibd-know-the-symptoms

KurkΓ³, J., Besenyei, T., Laki, J., Glant, T. T., Mikecz, K., & Szekanecz, Z. (2013). Genetics of Rheumatoid Arthritis β€” A Comprehensive Review. Clinical Reviews in Allergy & Immunology, 45(2), 170–179. https://doi.org/10.1007/s12016-012-8346-7

Kurowska, W., Kuca-Warnawin, E. H., Radzikowska, A., & MaΕ›liΕ„ski, W. (2017). The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis. Central European Journal of Immunology, 42(4), 390–398. https://doi.org/10.5114/ceji.2017.72807

Lester, T. (2024, March 4). The Role of Lifestyle Factors in Autoimmune Disease Management. Rupa Health. https://www.rupahealth.com/post/the-role-of-lifestyle-factors-in-autoimmune-disease-management

Li, Z., & Wang, X.-Q. (2023). Clinical effect and biological mechanism of exercise for rheumatoid arthritis: A mini review. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.1089621

Medina, Y. F., Ruiz, Á., & Acevedo, D. (2023). A Standardized Physical Examination Method for Joints to Determine Rheumatoid Arthritis Activity Using the Modified RAND/UCLA Appropriateness Method. Journal of Multidisciplinary Healthcare, Volume 16, 1287–1299. https://doi.org/10.2147/jmdh.s397038

Moudgil, K. D., & Choubey, D. (2011). Cytokines in Autoimmunity: Role in Induction, Regulation, and Treatment. Journal of Interferon & Cytokine Research, 31(10), 695–703. https://doi.org/10.1089/jir.2011.0065

Mueller, A.-L., Payandeh, Z., Mohammadkhani, N., Mubarak, S. M. H., Zakeri, A., Alagheband Bahrami, A., Brockmueller, A., & Shakibaei, M. (2021). Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies. Cells, 10(11), 3017. https://doi.org/10.3390/cells10113017

Neibling, K. (2023, March 22). Molecular Mimicry as a Mechanism of Autoimmune Disease. Rupa Health. https://www.rupahealth.com/post/molecular-mimicry-as-a-mechanism-of-autoimmune-disease

PabΓ³n-Porras, M. A., Molina-RΓ­os, S., FlΓ³rez-SuΓ‘rez, J. B., Coral-Alvarado, P. X., MΓ©ndez-Patarroyo, P., & Quintana-LΓ³pez, G. (2019). Rheumatoid arthritis and systemic lupus erythematosus: Pathophysiological mechanisms related to innate immune system. SAGE Open Medicine, 7, 205031211987614. https://doi.org/10.1177/2050312119876146

Paglia, M. D. G., Silva, M. T., Lopes, L. C., Barberato-Filho, S., Mazzei, L. G., Abe, F. C., & de CΓ‘ssia Bergamaschi, C. (2021). Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review and network meta-analysis. PLOS ONE, 16(4), e0248866. https://doi.org/10.1371/journal.pone.0248866

Pahwa, R., Jialal, I., & Goyal, A. (2019, June 4). Chronic Inflammation. NIH.gov; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK493173/

Pisetsky, D. S. (2023). Pathogenesis of Autoimmune Disease. Nature Reviews Nephrology, 19(8), 1–16. https://doi.org/10.1038/s41581-023-00720-1

Radu, A. F., & Bungau, S. G. (2021). Management of Rheumatoid Arthritis: an Overview. Cells, 10(11), 2857. https://doi.org/10.3390/cells10112857

Rheumatoid Factor by Access Labcorp Draw. (2020). Rupa Health. https://www.rupahealth.com/lab-tests/labcorp-rheumatoid-factor

Rheumatoid Factor by Access Med Labs. (n.d.). Rupa Health. https://www.rupahealth.com/lab-tests/access-medical-labs-rheumatoid-factor

Rojas-Villarraga, A., Amaya-Amaya, J., Rodriguez-Rodriguez, A., Mantilla, R. D., & Anaya, J.-M. (2012). Introducing Polyautoimmunity: Secondary Autoimmune Diseases No Longer Exist. Autoimmune Diseases, 2012, 1–9. https://doi.org/10.1155/2012/254319

Rosenblum, M. D., Gratz, I. K., Paw, J. S., & Abbas, A. K. (2012). Treating Human Autoimmunity: Current Practice and Future Prospects. Science Translational Medicine, 4(125), 125sr1–125sr1. https://doi.org/10.1126/scitranslmed.3003504

Salliot, C., Nguyen, Y., Boutron-Ruault, M.-C., & Seror, R. (2020). Environment and Lifestyle: Their Influence on the Risk of RA. Journal of Clinical Medicine, 9(10), 3109. https://doi.org/10.3390/jcm9103109

Sedimentation Rate (ESR) by Access Labcorp Draw. (2020). Rupa Health. https://www.rupahealth.com/lab-tests/labcorp-sedimentation-rate-esr

Shekhar, K. V., Pathak, M. M., & Gajanan Pisulkar. (2023). Diet and Lifestyle Impact on Rheumatoid Arthritis: A Comprehensive Review. Cureus. https://doi.org/10.7759/cureus.48625

Simon, T. A., Kawabata, H., Ray, N., Baheti, A., Suissa, S., & Esdaile, J. M. (2017). Prevalence of Co-existing Autoimmune Disease in Rheumatoid Arthritis: A Cross-Sectional Study. Advances in Therapy, 34(11), 2481–2490. https://doi.org/10.1007/s12325-017-0627-3

Sweetnich, J. (2023, May 15). Top Herbs and Supplements for Rheumatoid Arthritis: A Comprehensive Review. Rupa Health. https://www.rupahealth.com/post/top-herbs-and-supplements-for-rheumatoid-arthritis-a-comprehensive-review

Vojdani, A. (2022, April 25). The Importance of Detecting Autoimmune Diseases During Preclinical and Clinical Stage. Rupa Health. https://www.rupahealth.com/post/the-importance-of-detecting-autoimmune-diseases-during-preclinical-and-clinical-stage

Volkov, M., Schie, K. A., & Woude, D. (2019). Autoantibodies and B Cells: The ABC of rheumatoid arthritis pathophysiology. Immunological Reviews, 294(1), 148–163. https://doi.org/10.1111/imr.12829

Ward, L. (2019). Stress management as a patient-prioritised treatment target for rheumatoid arthritis in a New Zealand population. Clinical Medicine, 19(Suppl 2), s90–s90. https://doi.org/10.7861/clinmedicine.19-2-s90

Weinberg, J. (2022, July 8). Research Suggests an Imbalanced Gut Microbiome May Cause This Debilitating Autoimmune Disease. Rupa Health. https://www.rupahealth.com/post/research-suggests-an-imbalanced-gut-may-cause-this-debilitating-autoimmune-disease

Weinberg, J. (2023a, June 21). A comprehensive review of integrative approaches for the treatment of osteoarthritis: Diagnosis, differential diagnosis, and therapy options. Rupa Health. https://www.rupahealth.com/post/integrative-approaches-to-the-treatment-of-osteoarthritis-a-comprehensive-review

Weinberg, J. (2023b, July 27). Integrative Approaches to the Testing and Treatment of Rheumatoid Arthritis: A Comprehensive Review. Rupa Health. https://www.rupahealth.com/post/integrative-approaches-to-the-testing-and-treatment-of-rheumatoid-arthritis-a-comprehensive-review

Weinberg, J. L. (2022, July 28). Dry mouth and eyes are the first signs of this autoimmune disease. Rupa Health. https://www.rupahealth.com/post/what-is-sjogrens

Yap, H.-Y., Tee, S., Wong, M., Chow, S.-K., Peh, S.-C., & Teow, S.-Y. (2018). Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development. Cells, 7(10), 161. https://doi.org/10.3390/cells7100161

Yoshimura, H. (2023a, May 8). A Functional Medicine Systemic Lupus Erythematosus (SLE) Protocol: Testing, Diagnosing, and Treatment. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-systemic-lupus-erythematosus-sle-protocol-testing-diagnosing-and-treatment

Yoshimura, H. (2023b, October 10). A Root Cause Medicine Approach to Chronic Inflammation. Rupa Health. https://www.rupahealth.com/post/a-root-cause-medicine-approach-to-chronic-inflammation

Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
See All Magazine Articles
Trusted Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
CDC
Government Authority
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
National Institutes of Health
Government Authority
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Brain
Peer Reviewed Journal
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Chest
Peer Reviewed Journal
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source